| Released | Contributor | Author | Title | Pages | Price |
|---|
| Jun 18, 2013 | New Constructs, LLC | N/A | SNSS: Due Diligence Review: Forensic Earnings and Valuation | 13 | $25 | | Jun 14, 2013 | Pechala's Reports | Frantisek Pechala | SUNESIS PHARMACEUTICALS INC (SNSS) 12-months forecast | 1 | $15 | | Jun 13, 2013 | Wright Reports | N/A | Wright Industry Averages: Pharmaceuticals & Biotechnology (United States) | 77 | $885.50 | | Jun 13, 2013 | Wright Reports | N/A | Wright Industry Averages: Pharmaceuticals & Biotechnology (Global) | 105 | $1207.50 | | Jun 13, 2013 | Wright Reports | N/A | Wright Industry Averages: Pharmaceuticals & Biotechnology (North America) | 78 | $897 | | Jun 13, 2013 | Ford Investor Services, Inc. | N/A | Industry Value Graph: DYAI , OSIR , RPTP , SNSS -- DRUGS | 3 | $34.50 | | Jun 13, 2013 | Ford Investor Services, Inc. | N/A | Value Graph: SUNESIS PHARMA -- SNSS | 1 | $11.50 | | Jun 12, 2013 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for SNSS | 11 | $126.50 | | Jun 12, 2013 | Zacks Investment Research Inc. | N/A | SUNESIS PHARMA (SNSS) Zacks Company Snapshot | 1 | $11.50 | | Jun 9, 2013 | Wright Reports | N/A | Wright Investors Service Comprehensive Report for Sunesis Pharmaceuticals, Inc. | 41 | $471.50 |
|
View All Reports for SNSS ... |
|
|
1.35%